Jim Dulaney

Sr. Vice President US Commercialization, Moximed

[Jim Dulaney @JimDulaney136]

@0DonaldTrumpJr1 93

[Jim Dulaney @JimDulaney136]

@0DonaldTrumpJr1 786

[Jim Dulaney @JimDulaney136]

@0DonaldTrumpJr1 16

[Jim Dulaney @JimDulaney136]

@Nipi_220 Change purse

[Jim Dulaney @JimDulaney136]

@Teaseryy Oops…9

[Jim Dulaney @JimDulaney136]

@Teaseryy 10

[Jim Dulaney @JimDulaney136]

@RugbyMD Interesting timing for this message. Love it!!

[U.S. FDA @FDA]

Today’s “FDA Roundup” includes info on the MISHA Knee System and a virtual, public meeting. https://t.co/NHSdulFnPg

[Moximed @Moximed]

#BreakingNews: We’ve received FDA marketing authorization for the MISHA™ Knee System – an #ImplantableShockAbsorber for the knee indicated to treat medial #KneeOA:
https://t.co/fDEf2CQoMY]

#OrthoTwitter #SportsMedicine #MoveToMISHA

[Moximed @Moximed]

Myth or Fact? #KneeOA is an older person’s disease.

MYTH.

In fact, the majority of people with knee OA are working age (18-64 years).

#OrthoTwitter #OrthoSurgery

[Jim Dulaney @JimDulaney136]

@limberhealth @ucsfhealthaward Congrats to all the hard working people at Limber. Good luck.